Israel Englander Axsome Therapeutics, Inc. Put Options Transaction History

Millennium Management LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$78.93 - $95.84 $2.56 Million - $3.11 Million	32,400 New	32,400 $2.91 Million
Q1 2024 May 15, 2024	SELL	$69.39 - $97.64 $631,449 - $888,524	-9,100 Reduced 42.92%	12,100 $965,000
Q4 2023 Feb 14, 2024	BUY	$57.42 - $83.61 $976,140 - $1.42 Million	17,000 Added 404.76%	21,200 $1.69 Million
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $245,322 - $379,470	4,200 New	4,200 $301,000

326

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.23B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.